ACLX
Arcellx, Inc. Healthcare - Biotechnology Investor Relations →
Arcellx, Inc. (ACLX) closed at $114.77 as of 2026-03-20, trading 112.5% above its 200-week moving average of $54.00. The stock is currently moving closer to the line, down from 113.9% last week. With a 14-week RSI of 78, ACLX is in overbought territory.
Over the past 14 weeks, up-weeks have carried more volume than down-weeks (2.96 buyers-vs-sellers ratio). When trading picks up, it's more often on days the price is rising — buyers are showing more interest than sellers.
In 167 weeks of available data, ACLX has never crossed below its 200-week moving average. This suggests the stock has maintained a strong long-term uptrend throughout its history.
With a market cap of $6.7 billion, ACLX is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -53.4%. The stock trades at 16.5x book value.
Share count has increased 31.3% over three years, indicating dilution.
Over the past 3.2 years, a hypothetical investment of $100 in ACLX would have grown to $351, compared to $166 for the S&P 500. That represents an annualized return of 47.2% vs 17.0% for the index — confirming ACLX as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ACLX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
Historical Touches
ACLX has not crossed below its 200-week moving average in the available data (167 weeks).
Frequently Asked Questions
Is ACLX below its 200-week moving average?
No. Arcellx, Inc. (ACLX) is currently 112.5% above its 200-week moving average of $54.00. It would need to fall to $54.00 to cross below the line.
What is ACLX's 200-week moving average price?
Arcellx, Inc.'s 200-week moving average is $54.00 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
Is ACLX a good value right now?
Here's what our data says about ACLX as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 78 (overbought). Free cash flow is currently negative. Return on equity is -53.4%. Price-to-book is 16.5x. This is not a buy or sell recommendation — always do your own research.
How does ACLX compare to the S&P 500?
Over the past 3.2 years, $100 invested in ACLX would have grown to $351, compared to $166 for the S&P 500. That's 47.2% annualized vs 17.0% for the index. ACLX has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20